Geneva Capital Management LLC Bio Techne Corp Transaction History
Geneva Capital Management LLC
- $5.43 Billion
- Q2 2024
A detailed history of Geneva Capital Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 1,087,196 shares of TECH stock, worth $85.6 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
1,087,196
Previous 1,080,013
0.67%
Holding current value
$85.6 Million
Previous $76 Million
2.47%
% of portfolio
1.43%
Previous 1.35%
Shares
18 transactions
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.43 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.18 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$671 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$496 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$376 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $3.09B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...